Archives
-
ICAA Targets RIP3 in Cardiac Hypertrophy
2026-10-06
A 2026 Cellular Signalling study reports that isochlorogenic acid A reduces angiotensin II- and pressure overload-associated cardiac hypertrophy by targeting RIP3 and suppressing downstream CaMKII signaling. The work expands interpretation of RIP3 beyond canonical necroptosis and provides preclinical evidence for the RIP3/CaMKII axis, while leaving questions about human translation, pharmacology, and clinical efficacy unresolved.
-
Dorsomorphin 2HCl in AMPK and Liver Research
2026-10-06
This overview examines how Dorsomorphin 2HCl has been used as a pharmacological AMPK perturbation tool in a mouse model of alcohol-associated hepatic lipid accumulation. It compares the study’s findings with the limitations of inhibitor-based causal inference, microbiome and metabolomics correlations, and supplier-reported BMP and iron-regulation applications.
-
LP.P101, AMPK, and Alcohol-Related Liver Steatosis
2026-10-05
A 2025 study found that Lactiplantibacillus plantarum P101 reduced alcohol-associated hepatic lipid accumulation in mice, with pharmacological evidence implicating AMPK activation. By combining liver phenotyping with gut microbiota and serum metabolomics, the work connects probiotic intervention to a gut–liver metabolic mechanism while leaving important questions about causality and human translation unresolved.
-
Wnt-C59: Five Questions on PORCN Evidence
2026-10-05
A source-grounded overview of Wnt-C59 as a PORCN inhibitor, explaining its proposed mechanism, the strength of supplier-reported cancer evidence, links to Wnt/β-catenin biology, and the limits of extrapolating preclinical findings to regenerative medicine or clinical use.
-
Biotin (Vitamin B7): Research Context and Evidence
2026-10-04
Biotin is both a metabolic cofactor and a foundation for affinity-based molecular labeling. This overview examines its biochemical role, protein biotinylation, RNA interactome mapping, published findings, evidence strength, and research limitations.
-
MALAT1, miR-125b, and STAT3 in Sepsis PCT
2026-10-03
The reference study links the long noncoding RNA MALAT1 to procalcitonin expression through a miR-125b/STAT3 regulatory axis in sepsis-related clinical samples and an LPS-induced U937 cell model. Its main contribution is mechanistic framing: PCT variation may reflect post-transcriptional RNA regulation as well as inflammatory signaling, although the evidence remains largely preclinical and does not establish clinical diagnostic utility.
-
SR 11302: AP-1 Inhibitor Workflow Guide
2026-10-01
SR 11302 enables selective AP-1 pathway interrogation across cancer-cell and macrophage assays without the receptor activation associated with retinoids. This practical guide connects dose planning, TLR4-linked immunology, proliferation workflows, and troubleshooting for more defensible cancer research.
-
(S)-(+)-Ibuprofen: COX Inhibitor Research Guide
2026-10-01
(S)-(+)-Ibuprofen is the pharmacologically active ibuprofen enantiomer and a useful COX inhibitor for inflammation pathway research. This guide connects its cyclooxygenase mechanism, benchmark concentrations, environmental activity, formulation limits, and practical workflow controls.
-
3-Deazaadenosine Hydrochloride: Assay Logic
2026-09-30
3-Deazaadenosine hydrochloride is a selective S-adenosylhomocysteine hydrolase inhibitor for dissecting methylation-dependent biology. This article presents a causal assay framework linking SAHH perturbation with IGF2BP1–TUBB4B signaling in hepatic stellate cells while separating global methyl-metabolism effects from pathway-specific conclusions.
-
Biotin (Vitamin B7) for Motor Protein Assays
2026-09-30
Biotin (Vitamin B7) supports two complementary research needs: selective avidin or streptavidin-based detection and mechanistic metabolic assays involving carboxylases. This guide shows how to build, control, and troubleshoot labeling workflows while translating recent BicD–MAP7 kinesin findings into practical assay design choices.
-
3-Deazaadenosine HCl in Fibrosis Research
2026-09-29
3-Deazaadenosine hydrochloride offers translational researchers a controllable way to perturb SAHH-dependent methyl metabolism while investigating the IGF2BP1–m6A–TUBB4B–FAK axis in hepatic stellate cells. This thought-leadership article connects the compound’s biochemical rationale with experimental controls, assay design, competitive positioning, and the limits that must be addressed before methylation biology can inform antifibrotic development.
-
NLG1 Proteolysis Sustains Social Memory
2026-09-29
The reference study identifies a proteolytic mechanism in which social interaction triggers α- and γ-secretase processing of Neuroligin 1 in the ventral hippocampus. The resulting intracellular NLG1-CTD fragment engages PDZ-dependent signaling and cofilin regulation to strengthen synapses and maintain social memory.
-
ATP Solution in Translational p21 mRNA Research
2026-09-28
Translational mRNA research depends on more than delivery design: it requires a controlled biochemical evidence chain. This article examines how ATP quality supports kinase, transcription, ligation, and phosphorylation workflows that help de-risk p21 mRNA–LNP development for localized bladder cancer therapy.
-
Biotin (Vitamin B7) for Research Workflows
2026-09-28
Use Biotin to connect carboxylase-focused metabolic experiments with affinity-based detection workflows, while keeping free biotin distinct from activated labeling reagents. This guide also shows how to study the shrimp STING antiviral response without implying that biotin was tested in the reference study.
-
Sulfo-NHS-SS-Biotin for Surface Protein Mapping
2026-09-27
Map accessible cell-surface proteins and recover them through streptavidin workflows with a water-soluble biotin reagent whose disulfide linker can be cleaved for target release. The kit supports both intact-cell surface labeling and protein or antibody workflows, while careful controls help distinguish surface-protein evidence from direct glycoRNA detection.